Amedisys ROE 2010-2024 | AMED

Current and historical return on equity (ROE) values for Amedisys (AMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Amedisys ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $0.08B $1.20B 7.07%
2024-06-30 $0.09B $1.18B 8.02%
2024-03-31 $-0.02B $1.14B -1.90%
2023-12-31 $-0.01B $1.12B -0.91%
2023-09-30 $0.00B $1.09B 0.27%
2023-06-30 $0.00B $1.06B 0.27%
2023-03-31 $0.11B $1.13B 10.39%
2022-12-31 $0.12B $1.11B 11.33%
2022-09-30 $0.12B $1.07B 11.89%
2022-06-30 $0.14B $1.04B 14.15%
2022-03-31 $0.19B $1.02B 19.99%
2021-12-31 $0.21B $0.98B 23.28%
2021-09-30 $0.22B $0.95B 25.69%
2021-06-30 $0.25B $0.88B 30.54%
2021-03-31 $0.20B $0.79B 26.23%
2020-12-31 $0.18B $0.81B 24.77%
2020-09-30 $0.17B $0.76B 23.84%
2020-06-30 $0.13B $0.72B 19.49%
2020-03-31 $0.13B $0.68B 20.58%
2019-12-31 $0.13B $0.64B 21.81%
2019-09-30 $0.13B $0.60B 23.23%
2019-06-30 $0.12B $0.56B 24.45%
2019-03-31 $0.12B $0.52B 26.26%
2018-12-31 $0.12B $0.48B 25.01%
2018-09-30 $0.09B $0.45B 18.13%
2018-06-30 $0.07B $0.41B 14.29%
2018-03-31 $0.04B $0.55B 8.11%
2017-12-31 $0.03B $0.52B 5.99%
2017-09-30 $0.04B $0.51B 8.82%
2017-06-30 $0.04B $0.49B 8.28%
2017-03-31 $0.05B $0.48B 10.12%
2016-12-31 $0.04B $0.46B 8.48%
2016-09-30 $0.04B $0.45B 9.68%
2016-06-30 $0.04B $0.43B 9.25%
2016-03-31 $0.04B $0.41B 9.53%
2015-12-31 $-0.00B $0.41B -0.77%
2015-09-30 $-0.01B $0.39B -1.82%
2015-06-30 $-0.01B $0.38B -1.83%
2015-03-31 $-0.01B $0.37B -2.63%
2014-12-31 $0.01B $0.40B 3.43%
2014-09-30 $-0.01B $0.38B -1.61%
2014-06-30 $-0.11B $0.37B -28.30%
2014-03-31 $-0.11B $0.36B -28.14%
2013-12-31 $-0.10B $0.37B -22.90%
2013-09-30 $-0.19B $0.38B -43.89%
2013-06-30 $-0.09B $0.47B -18.84%
2013-03-31 $-0.09B $0.46B -16.95%
2012-12-31 $-0.08B $0.45B -16.02%
2012-09-30 $0.03B $0.57B 4.99%
2012-06-30 $-0.41B $0.54B -77.41%
2012-03-31 $-0.39B $0.53B -63.08%
2011-12-31 $-0.38B $0.52B -53.45%
2011-09-30 $-0.37B $0.51B -45.26%
2011-06-30 $0.08B $0.93B 9.10%
2011-03-31 $0.09B $0.90B 10.52%
2010-12-31 $0.11B $0.88B 13.53%
2010-09-30 $0.13B $0.85B 16.15%
2010-06-30 $0.14B $0.83B 18.85%
2010-03-31 $0.15B $0.78B 20.50%
2009-12-31 $0.14B $0.74B 20.43%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.948B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00